Skip to content
Screener

Bio-Techne TECH Prepaid & Other Current

Prepaid & Other Current at other companies

Danaher logo
DanaherDHR
$1.81B+1.1%
Bruker logo
BrukerBRKR
$46.6M-6.2%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$19.39M-4.8%
Revvity logo
RevvityRVTY
$189.11M+4.1%
Agilent Technologies logo
Agilent TechnologiesA
$369M+1.1%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$150M+19.6%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$11.22B+43.5%
Enterprise value$11.3B+39.5%
P/E74.9×+16.9×
P/S9.3×+2.9×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:31 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056302
Line itemMarch 31, 2026 / (unaudited)June 30, 2025
Accounts receivable, less allowances of $4,415 and $4,215, respectively214,562206,876
Inventories201,175189,446
Current assets held-for-sale12,332
Other current assets62,49437,460
Total current assets688,050608,300
Property and equipment, net232,990245,719
Right-of-use assets68,31673,399
Goodwill977,800980,935

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Bio-Techne's prepaid & other current?
Bio-Techne (TECH) reported prepaid & other current of $62.49M in Q1 2026.
How has Bio-Techne's prepaid & other current changed year-over-year?
Bio-Techne's prepaid & other current increased by 16.5% year-over-year, from $53.65M to $62.49M.
What is the long-term trend for Bio-Techne's prepaid & other current?
Over 4 years (2021 to 2025), Bio-Techne's prepaid & other current has grown at a 22.0% compound annual growth rate (CAGR), from $16.92M to $37.46M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Bio-Techne's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude